Sign in

Filings

Finds words inside filing documents. Searching Benitec Biopharma Inc.'s filings · 35 documents indexed.

15 documents · 59 matches

  1. BNTC Benitec Biopharma Inc. 10-K 2025-09-22

    Item 1A.

    material weakness identified in connection with the restatement, or that any additional material weaknesses or restatements of financial results will
    20 matches in this document

  2. BNTC Benitec Biopharma Inc. 10-K 2026-09-14

    Item 1A. Risk Factors.

    material weaknesses or other control deficiencies will not be identified in the future. If we experience material weaknesses in our internal
    8 matches in this document

  3. BNTC Benitec Biopharma Inc. 8-K 2026-09-24

    Item 4.01. Changes in Registrant’s Certifying Accountant.

    material weakness in the Company’s internal control over financial reporting, as reported in Item 9A of Part II of the Company
    1 match in this document

  4. BNTC Benitec Biopharma Inc. 10-Q 2026-02-12

    Item 4. Controls and Procedures

    material weakness related to the inadequate design and implementation of controls over our share-based compensation calculation review process has been
    7 matches in this document

  5. BNTC Benitec Biopharma Inc. 10-Q 2026-05-14

    Item 4. Controls and Procedures

    material weakness related to the inadequate design and implementation of controls over our share-based compensation calculation review process has been
    7 matches in this document

  6. BNTC Benitec Biopharma Inc. 10-Q 2025-11-14

    Item 4. Controls and Procedures

    material weakness as previously described above, there were no changes in our internal controls over financial reporting during the quarter
    4 matches in this document

  7. BNTC Benitec Biopharma Inc. 10-Q 2025-05-14

    Item 4. Controls and Procedures

    material weakness as previously described above, there were no changes in our internal controls over financial reporting during the quarter
    4 matches in this document

  8. BNTC Benitec Biopharma Inc. 8-K 2026-05-14

    material weakness in our internal control over financial reporting; the Company’s ability to satisfy its capital needs through increasing
    1 match in this document

  9. BNTC Benitec Biopharma Inc. 8-K 2026-02-12

    material weakness in our internal controls over financial reporting; the impact of local, regional, and national and international economic conditions
    1 match in this document

  10. BNTC Benitec Biopharma Inc. 8-K 2025-11-14

    material weakness in our internal controls over financial reporting; the impact of local, regional, and national and international economic conditions
    1 match in this document

  11. BNTC Benitec Biopharma Inc. 8-K 2025-11-03

    material weakness in our internal controls over financial reporting, the impact of local, regional, and national and international economic conditions
    1 match in this document

  12. BNTC Benitec Biopharma Inc. 8-K 2025-11-03

    material weakness in our internal controls over financial reporting, the impact of local, regional, and national and international economic conditions
    1 match in this document

  13. BNTC Benitec Biopharma Inc. 8-K 2025-11-03

    material weakness in our internal controls over financial reporting; the impact of local, regional, and national and international economic conditions
    1 match in this document

  14. BNTC Benitec Biopharma Inc. 8-K 2025-09-22

    material weakness in our internal controls over financial reporting; the impact of local, regional, and national and international economic conditions
    1 match in this document

  15. BNTC Benitec Biopharma Inc. 8-K 2025-07-09

    material weakness in our internal controls over financial reporting; the impact of local, regional, and national and international economic conditions
    1 match in this document

Page 1 of 1 · 15 documents